acord cadru de furnizare medicamente din grupa ; "antineoplazice si imunomodulatoare- Pembrolizumabum conc pt sol perf 25mg/ml - "
Buyer: SPITALUL CLINIC JUDETEAN MURES
- Published
- 6 July 2026
- Estimated value
- 22,083,500 RON
- Place of performance
- RO125
- Procedure
- open
- Lots
- 1
- Notice number
- 00461035-2026
- Reference
- 48cc97e2-0bd6-4ffc-8952-4bf2e9d435c2
- Official source
- Official source
CPV codes
- 33652000Agentes antineoplásicos e inmunomoduladores
Description
Pembrolizumabum conc pt sol perf 25mg/ml - ac min 150- max 2000 css min 5- max 10 val ac : min 1656262.5- max 22083500 val css - min 55209-max 110418. valaore garantie de participare 1104.18
Awards
| Awarded to | Amount | Date |
|---|---|---|
| FARMEXIM S.A. | 21,598,780 RON | — |
| DR.MAX | 21,585,940 RON | — |
| Merck Sharp & Dohme Romania | 21,559,820 RON | — |
| Merck Sharp & Dohme Romania | 592,895 RON | — |
| Merck Sharp & Dohme Romania | 592,895 RON | — |
| Merck Sharp & Dohme Romania | 592,895 RON | — |
| Merck Sharp & Dohme Romania | 409,637 RON | — |
| Merck Sharp & Dohme Romania | 269,498 RON | — |
| Merck Sharp & Dohme Romania | 183,258 RON | — |
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is 22,083,500 RON.
- Who is the buyer of this tender?
- The contracting authority is SPITALUL CLINIC JUDETEAN MURES (European Union).
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.